Stifel Nicolaus analyst Annabel Samimy maintained a Buy rating on Altimmune (ALT – Research Report) today and set a price target of $18.00. The ...

Shares in financial firm Stifel (SF) dropped 3% today after it was told to cough up $132.5 million in damages to a U.S.

Stifel Financial was ordered by a Financial Industry Regulatory Authority arbitration panel to pay a family $132.5 million ...

While Adobe beat on the top- and bottom-line for its fiscal first quarter and gave solid fiscal Q2 guidance, its net new ...